Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay.


Por: Köser CU, Comas I, Feuerriegel S, Niemann S, Gagneux S and Peacock SJ

Fecha de Publicación: 01/07/2014
Resumen:


Direcciones
Köser CU: Department of Medicine, University of Cambridge, Cambridge, United Kingdom
Comas I: Genomics and Health Unit, FISABIO, Valencia, Spain; CIBER (Centros de Investigación Biomédica en Red) in Epidemiology and Public Health, Spain
Feuerriegel S: Molecular Mycobacteriology, Borstel, Germany; German Centre for Infection Research, Research Centre Borstel, Borstel, Germany
Niemann S: Molecular Mycobacteriology, Borstel, Germany; German Centre for Infection Research, Research Centre Borstel, Borstel, Germany
Gagneux S: Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland
Peacock SJ: Department of Medicine, University of Cambridge, Cambridge, United Kingdom; Clinical Microbiology and Public Health Laboratory, Public Health England, Cambridge, United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom
ISSN: 14729792





Tuberculosis
Editorial
Churchill Livingstone, Estados Unidos America
Tipo de documento: Letter
Volumen: 94 Número: 4
Páginas: 451-453s
WOS: 000338620700013
ID de PubMed: 24870943

MÉTRICAS